ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,291, issued on Sept. 29, was assigned to H. LUNDBECK A/S (Valby, Denmark). "Nucleic acids encoding humanized anti-PACAP antibodies" was in... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,292, issued on Sept. 29, was assigned to Incyte Corp. (Wilmington, Del.). "Anti-tumor combination therapy comprising anti-CD19 antibody an... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,293, issued on Sept. 29, was assigned to Cullinan Mica Corp. (Cambridge, Mass.). "MICA/B antibodies and methods of use" was invented by Ne... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,294, issued on Sept. 29, was assigned to H. Lundbeck A/S (Valby, Denmark). "Anti-Sortilin antibodies and use thereof" was invented by Lars... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,296, issued on Sept. 29, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Anti-CCR8 antibodies for treating cancer" was invent... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,297, issued on Sept. 29, was assigned to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Suwon-si, South Korea). "Bispecific ant... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,298, issued on Sept. 29, was assigned to TeneoBio Inc. (Thousand Oaks, Calif.). "Multi-specific antibodies binding to BCMA" was invented b... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,299, issued on Sept. 29, was assigned to Memorial Sloan Kettering Cancer Center (New York) and Tri-Institutional Therapeutics Discovery Ins... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,300, issued on Sept. 29, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Methods and antibody compositions for tumor tr... Read More
ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,301, issued on Sept. 29, was assigned to The University of Hong Kong (Hong Kong). "Use of LANCL1 and antibodies thereof as a diagnostic an... Read More